Tuesday, December 2, 2008 - 8:23PM EST

General Interest Articles

21. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.

Author
Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP;
Institution
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. harris.peter@mayo.edu
Journal
J Am Soc Nephrol. 2006 Nov;17(11):3013-9. Epub 2006 Oct 11.
Abstract URL
Click here to view abstract

22. Predominant extrahepatic biliary disease in autosomal recessive polycystic kidney disease: a new association.

Author
Goilav B; Norton KI; Satlin LM; Guay-Woodford L; Chen F; Magid MS; Emre S; Shneider BL;
Institution
Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA.
Journal
Pediatr Transplant. 2006 May;10(3):294-8.
Abstract URL
Click here to view abstract

23. Overexpression of PKD1 causes polycystic kidney disease.

Author
Thivierge C; Kurbegovic A; Couillard M; Guillaume R; Cote O; Trudel M;
Institution
Institut de Recherches Cliniques de Montreal, Molecular Genetics and Development, 110 ave. des Pins ouest, Montreal, Quebec, Canada H2W 1R7.
Journal
Mol Cell Biol. 2006 Feb;26(4):1538-48.
Abstract URL
Click here to view abstract

24. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.

Author
Taylor M; Johnson AM; Tison M; Fain P; Schrier RW;
Institution
University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Journal
Am J Kidney Dis. 2005 Sep;46(3):415-23.
Abstract URL
Click here to view abstract

25. Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD).

Author
Bergmann C; Senderek J; Windelen E; Kupper F; Middeldorf I; Schneider F; Dornia C; Rudnik-Schoneborn S; Konrad M; Schmitt CP; Seeman T; Neuhaus TJ; Vester U; Kirfel J; Buttner R; Zerres K;
Institution
Department of Human Genetics, Aachen University, Aachen, Germany. cbergmann@ukaachen.de
Journal
Kidney Int. 2005 Mar;67(3):829-48.
Abstract URL
Click here to view abstract

26. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.

Author
de Mattos AM; Olyaei AJ; Prather JC; Golconda MS; Barry JM; Norman DJ;
Institution
Renal Transplant Program, Oregon Health & Science University, Portland, Oregon, USA. demattos@uab.edu
Journal
Kidney Int. 2005 Feb;67(2):714-20.
Abstract URL
Click here to view abstract

27. Volume progression in polycystic kidney disease.

Author
Grantham JJ; Torres VE; Chapman AB; Guay-Woodford LM; Bae KT; King BF Jr; Wetzel LH; Baumgarten DA; Kenney PJ; Harris PC; Klahr S; Bennett WM; Hirschman GN; Meyers CM; Zhang X; Zhu F; Miller JP; Grantham JJ; Torres VE; Chapman AB; Guay-Woodford LM; Bae KT; King BF Jr; Wetzel LH; Baumgarten DA; Kenney PJ; Harris PC; Klahr S; Bennett WM; Hirschman GN; Meyers CM; Zhang X; Zhu F; Miller JP;
Institution
Kidney Institute and the Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66160, USA. jgrantha@kumc.edu
Journal
N Engl J Med. 2006 May 18;354(20):2122-30.
Abstract URL
Click here to view abstract

28. A successful treatment of life-threatening bleeding from polycystic kidneys with antifibrinolytic agent tranexamic acid.

Author
Vujkovac B; Sabovic M;
Institution
Department for Nephrology and Dialysis, General Hospital, Slovenj Gradec, Slovenia.
Journal
Blood Coagul Fibrinolysis. 2006 Oct;17(7):589-91.
Abstract URL
Click here to view abstract

29. CRISP: opening a new frontier in the diagnosis and treatment of PKD.

Author
Grantham JJ;
Institution
Kidney Institute and Department of Internal Medicine, Kansas University Medical Center, Kansas City, USA.
Journal
Nephrol News Issues. 2006 Aug;20(9):29-30.

30. New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver.

Author
Ubara Y;
Institution
Nephrology Center, Toranomon Hospital, Kajigaya, Kanagawa, Japan. ubara@toranomon.gr.jp
Journal
Ther Apher Dial. 2006 Aug;10(4):333-41.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5